Katarzyna Waszak
Poznan, WP, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: February 09, 2026
Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
Journal: Canadian journal of gastroenterology & hepatology
Published: May 19, 2025
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).
Journal: Therapeutic advances in gastroenterology
Published: January 31, 2024
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
Journal: Therapeutic advances in gastroenterology
Published: May 06, 2022
Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients.
Journal: Journal of clinical medicine
Published: June 29, 2021
Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2.
Journal: Polish archives of internal medicine
Published: February 05, 2021
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).
Journal: Therapeutic advances in gastroenterology
Published: December 01, 2020
Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease.
Journal: Frontiers in immunology
Published: October 09, 2020
Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region.
Journal: Polish archives of internal medicine
Published: July 31, 2018
Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseases.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: March 21, 2018
Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?
Journal: Archives of medical science : AMS
Published: November 21, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026